ReP USP - Resultado da busca

Artigo de periodico
Cruzain inhibitors: state-of-art of novel synthetic strategies (2023)
Morais, Pedro Alves Bezerra ; Trossini, Gustavo Henrique Goulart
Source: Current Organic Chemistry. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, SÍNTESE ORGÂNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, Pedro Alves Bezerra e TROSSINI, Gustavo Henrique Goulart. Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, v. 27, n. 4, p. 243-247, 2023Tradução . . Disponível em: https://doi.org/10.2174/1385272827666230418100932. Acesso em: 13 nov. 2024.
APA
Morais, P. A. B., & Trossini, G. H. G. (2023). Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, 27( 4), 243-247. doi:10.2174/1385272827666230418100932
NLM
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Vancouver
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Artigo de periodico
Insights into newly approved drugs from a medicinal chemistry perspective (2021)
Lima, Elys Juliane Cardoso ; Gomes, Renan Augusto ; Fornari, Evelin; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 13 nov. 2024.
APA
Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
NLM
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Vancouver
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Artigo de periodico
Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification (2018)
Teles, Andre Lacerda Braga; Silva, Roseane R; Ko, Michelle; Ferreira, Glaucio Monteiro; Pita, Samuel da Rocha; Trossini, Gustavo Henrique Goulart ; Carvalho, Paulo; Castilho, Marcelo Santos
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: MODELAGEM MOLECULAR, SCHISTOSOMA MANSONI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELES, Andre Lacerda Braga et al. Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification. Current Topics in Medicinal Chemistry, v. 18, p. 406-417, 2018Tradução . . Disponível em: https://doi.org/10.2174/1568026618666180509150134. Acesso em: 13 nov. 2024.
APA
Teles, A. L. B., Silva, R. R., Ko, M., Ferreira, G. M., Pita, S. da R., Trossini, G. H. G., et al. (2018). Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification. Current Topics in Medicinal Chemistry, 18, 406-417. doi:10.2174/1568026618666180509150134
NLM
Teles ALB, Silva RR, Ko M, Ferreira GM, Pita S da R, Trossini GHG, Carvalho P, Castilho MS. Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18 406-417.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1568026618666180509150134
Vancouver
Teles ALB, Silva RR, Ko M, Ferreira GM, Pita S da R, Trossini GHG, Carvalho P, Castilho MS. Identification, characterization and molecular modelling studies of schistosoma mansoni dihydrofolate reductase inhibitors: From assay development to hit identification [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18 406-417.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1568026618666180509150134
Artigo de periodico
Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells (2018)
Fernandes, Thais Batista; Azevedo, Ricardo Alexandre de; Yang, Rosania; Teixeira, Sarah Fernandes; Trossini, Gustavo Henrique Goulart ; Barbuto, José Alexandre Marzagão ; Ferreira, Adilson Kleber; Parise Filho, Roberto
Source: Letters in Drug Design and Discovery. Unidades: FCF, ICB
Subjects: APOPTOSE, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Thais Batista et al. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, v. 15, n. 12, p. 1288-1298, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570180815666180321161513. Acesso em: 13 nov. 2024.
APA
Fernandes, T. B., Azevedo, R. A. de, Yang, R., Teixeira, S. F., Trossini, G. H. G., Barbuto, J. A. M., et al. (2018). Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, 15( 12), 1288-1298. doi:10.2174/1570180815666180321161513
NLM
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1570180815666180321161513
Vancouver
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1570180815666180321161513
Artigo de periodico
Advances and challenges in drug design of PPARδ ligands (2018)
Maltarollo, Vinícius Gonçalves ; Kronenberger, Thales ; Windshuegel, Bjoern ; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honório, Káthia Maria
Source: Current Drug Targets. Unidades: ICB, FCF, EACH
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, SÍNDROME X METABÓLICA, ÁCIDOS GRAXOS, DOENÇAS METABÓLICAS, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, v. 19, n. 2, p. 144-154, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389450118666170414113159. Acesso em: 13 nov. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Windshuegel, B., Wrenger, C., Trossini, G. H. G., & Honório, K. M. (2018). Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, 19( 2), 144-154. doi:10.2174/1389450118666170414113159
NLM
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Vancouver
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Artigo de periodico
New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches (2014)
Bueno, Renata Vieria; Braga, Rodolpho de Campos; Segretti, Natanael Dante; Ferreira, Elizabeth Igne ; Trossini, Gustavo Henrique Goulart ; Andrade, Carolina Horta
Source: Current Pharmaceutical Design. Unidade: FCF
Subjects: TUBERCULOSE, ÁCIDOS NUCLEICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Renata Vieria et al. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, v. 20, n. 27, p. 4474-4485, 2014Tradução . . Acesso em: 13 nov. 2024.
APA
Bueno, R. V., Braga, R. de C., Segretti, N. D., Ferreira, E. I., Trossini, G. H. G., & Andrade, C. H. (2014). New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, 20( 27), 4474-4485.
NLM
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2024 nov. 13 ]
Vancouver
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2024 nov. 13 ]
Artigo de periodico
Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides (2014)
Vital, Drielli Gomes; Arribas, Marco; Trossini, Gustavo Henrique Goulart
Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: MODELAGEM MOLECULAR, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VITAL, Drielli Gomes e ARRIBAS, Marco e TROSSINI, Gustavo Henrique Goulart. Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides. Letters in Drug Design & Discovery, v. 11, n. 3, p. 249-255, 2014Tradução . . Acesso em: 13 nov. 2024.
APA
Vital, D. G., Arribas, M., & Trossini, G. H. G. (2014). Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides. Letters in Drug Design & Discovery, 11( 3), 249-255.
NLM
Vital DG, Arribas M, Trossini GHG. Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides. Letters in Drug Design & Discovery. 2014 ; 11( 3): 249-255.[citado 2024 nov. 13 ]
Vancouver
Vital DG, Arribas M, Trossini GHG. Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides. Letters in Drug Design & Discovery. 2014 ; 11( 3): 249-255.[citado 2024 nov. 13 ]
Artigo de periodico
The survey of the use of QSAR methods to determine intestinal absorption and oral bioavailability during drug design (2014)
Silva, Fredson Torres; Trossini, Gustavo Henrique Goulart
Source: Medicinal Chemistry. Unidade: FCF
Subjects: BIODISPONIBILIDADE, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Fredson Torres e TROSSINI, Gustavo Henrique Goulart. The survey of the use of QSAR methods to determine intestinal absorption and oral bioavailability during drug design. Medicinal Chemistry, v. 10, n. 5, p. 441-448, 2014Tradução . . Acesso em: 13 nov. 2024.
APA
Silva, F. T., & Trossini, G. H. G. (2014). The survey of the use of QSAR methods to determine intestinal absorption and oral bioavailability during drug design. Medicinal Chemistry, 10( 5), 441-448.
NLM
Silva FT, Trossini GHG. The survey of the use of QSAR methods to determine intestinal absorption and oral bioavailability during drug design. Medicinal Chemistry. 2014 ; 10( 5): 441-448.[citado 2024 nov. 13 ]
Vancouver
Silva FT, Trossini GHG. The survey of the use of QSAR methods to determine intestinal absorption and oral bioavailability during drug design. Medicinal Chemistry. 2014 ; 10( 5): 441-448.[citado 2024 nov. 13 ]
Artigo de periodico
Nitric oxide: State of the art in drug design (2012)
Serafim, Ricardo Augusto Massarico; Primi, Marina Candido; Trossini, Gustavo Henrique Goulart ; Ferreira, Elizabeth Igne
Source: Current Medicinal Chemistry. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERAFIM, Ricardo Augusto Massarico et al. Nitric oxide: State of the art in drug design. Current Medicinal Chemistry, v. 19, n. 3, p. 386-405, 2012Tradução . . Disponível em: https://doi.org/10.2174/092986712803414321. Acesso em: 13 nov. 2024.
APA
Serafim, R. A. M., Primi, M. C., Trossini, G. H. G., & Ferreira, E. I. (2012). Nitric oxide: State of the art in drug design. Current Medicinal Chemistry, 19( 3), 386-405. doi:10.2174/092986712803414321
NLM
Serafim RAM, Primi MC, Trossini GHG, Ferreira EI. Nitric oxide: State of the art in drug design [Internet]. Current Medicinal Chemistry. 2012 ; 19( 3): 386-405.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/092986712803414321
Vancouver
Serafim RAM, Primi MC, Trossini GHG, Ferreira EI. Nitric oxide: State of the art in drug design [Internet]. Current Medicinal Chemistry. 2012 ; 19( 3): 386-405.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/092986712803414321
Artigo de periodico
Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs (2010)
Trossini, Gustavo Henrique Goulart ; Chin, Chung Man; Menezes, Carla Maria de Souza; Ferreira, Elizabeth Igne
Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PROTEINASES, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROSSINI, Gustavo Henrique Goulart et al. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, v. 7, n. 7, p. 528-533, 2010Tradução . . Disponível em: https://doi.org/10.2174/157018010791526287. Acesso em: 13 nov. 2024.
APA
Trossini, G. H. G., Chin, C. M., Menezes, C. M. de S., & Ferreira, E. I. (2010). Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, 7( 7), 528-533. doi:10.2174/157018010791526287
NLM
Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/157018010791526287
Vancouver
Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/157018010791526287

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Non normalized affiliation